Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print February 14, 2008
DOI: 10.2337/db07-1214

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-1214v1
db07-1214v2
57/5/1205    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferdaoussi, M.
Right arrow Articles by Abderrahmani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferdaoussi, M.
Right arrow Articles by Abderrahmani, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Exendin-4 protects β-cells from interleukin 1β-induced apoptosis by interfering with the c-Jun N-terminal kinases pathway

Mourad Ferdaoussi, Ph.D.1,,2, Saida Abdelli, Ph.D.1,,2, Jiang-Yan Yang, Ph.D.2,,3, Marion Cornu, Ph.D.3,,4, Guy Niederhauser, M.SC.1,,2, Dimitri Favre, Ph.D.1,,2, Christian Widmann, Ph.D.2,,3, Romano Regazzi, Ph.D.2, Bernard Thorens, Ph.D.3,,4, Gérard Waeber, MD.1, and Amar Abderrahmani, Ph.D.1,,2

1Service of Internal Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland
2Department of Cellular Biology and Morphology, University of Lausanne, CH-1005 Lausanne, Switzerland
3Department of Physiology, University of Lausanne, CH-1005 Lausanne, Switzerland
4Center for integrative Genomics, University of Lausanne, CH-1005 Lausanne, Switzerland

Objective: The pro-inflammatory cytokine interleukin-1β (IL-1β) generates pancreatic β-cells apoptosis mainly through activation of the c-Jun Amino terminal Kinase (JNK) pathway. This study was designed to investigate whether the long-acting agonist of the hormone Glucagon-like peptide-1 (GLP-1) receptor exendin-4 (ex-4), which mediates protective effects against-cytokines-induced β-cell apoptosis, could interfere with the JNK pathway.

Research Design and Methods: Isolated human, rat and mouse islets as well as the rat insulin-secreting INS-1E cells were incubated with ex-4 in the presence or absence of IL-1β. JNK activity was assessed by solid-phase JNK kinase assay and quantification of c-Jun expression. Cell apoptosis was determined by scoring cells displaying pycnotic nuclei

Results: Ex-4 inhibited induction of the JNK pathway elicited by IL-1β. This effect was mimicked with the use of cAMP-raising agents IBMX and Foskolin (I/F) and required activation of the protein kinase A (PKA). Inhibition of the JNK pathway by ex-4 and I/F was concomitant with a rise in the levels of Islet-Brain 1 (IB1), a potent blocker of the stress-induced JNK pathway. In fact, ex-4 as well as I/F induced expression of IB1 at the promoter level through the CRE binding transcription factor 1. Suppression of IB1 levels with the use of RNA interference strategy impaired the protective effects of ex-4 against apoptosis induced by IL-1β

Conclusion: The data establish the requirement of IB1 in the protective action of ex-4 against apoptosis elicited by IL-1β and highlight the GLP-1 mimetics as new potent inhibitors of the JNK signalling induced by cytokines.


Correspondence: Amar.Abderrahmani{at}unil.ch


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.